ABOUT US
OUR PEOPLE
Advancing science with purpose and experience
Uniquity Bio was built by a team of seasoned pharma and biotech executives with deep expertise in immunology and inflammation — extending across the entire drug development cycle — and a shared purpose of propelling scientific innovation to deliver new best-in-class treatments for immune-mediated diseases. Many of us have worked together for decades, and we know what it takes to build strong companies and important new medicines.
Meet the team that sets Uniquity apart.
Our Leaders
Our Team
Nasiba Abdul-Karim
Senior Director, Pharmacovigilance
Katie Bothwell, MPH, CAPM, PMP
Director, Manufacturing Development and Operations Project Management
Michael Finkle
Director, Regulatory Operations
Chad Johnson
Senior Director, Drug Product Manufacturing
Joseph "Joe" Kuzo
Senior Director, Clinical Supply Strategy and Product Supply Chain
Daniel Miconi
Director, Clinical Operations
Samantha Schoettle
Executive Administrator
Melissa Walker
Executive Administrative Assistant
Amy Woo, MPH
Senior Director, Clinical Operations
Hema Balasubramanian
Senior Director, Regulatory Affairs
Joann DeLucca
Manager, Office and Contracts Administration
Amy Frailey, MPH
Senior Director, Clinical Development Operations
Isabel Kanholm, MPH
Executive Program Coordinator
Bojan Lalovic, Ph.D.
Senior Director, Clinical Pharmacology
Michael Reid
Senior Director, GMP QA Management
Theresa Sheehan
Senior Director, Quality Assurance and Compliance
Kurt Wong, Ph.D.
Director, Translational Medicine
Peng Yu, Ph.D.
Senior Director, Analytical Development